Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.

Edwards DN, Ngwa VM, Wang S, Shiuan E, Brantley-Sieders DM, Kim LC, Reynolds AB, Chen J.

Sci Signal. 2017 Dec 5;10(508). pii: eaan4667. doi: 10.1126/scisignal.aan4667.

PMID:
29208682
2.

Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.

Shiuan E, Beckermann KE, Ozgun A, Kelly C, McKean M, McQuade J, Thompson MA, Puzanov I, Greer JP, Rapisuwon S, Postow M, Davies MA, Eroglu Z, Johnson D.

J Immunother Cancer. 2017 Feb 21;5:8. doi: 10.1186/s40425-017-0210-0. eCollection 2017.

3.

Eph Receptor Tyrosine Kinases in Tumor Immunity.

Shiuan E, Chen J.

Cancer Res. 2016 Nov 15;76(22):6452-6457. doi: 10.1158/0008-5472.CAN-16-1521. Epub 2016 Nov 3. Review.

4.

Patient-Level Adverse Event Patterns in a Single-Institution Study of the Multi-Kinase Inhibitor Sorafenib.

Karovic S, Shiuan EF, Zhang SQ, Cao H, Maitland ML.

Clin Transl Sci. 2016 Jul 21. doi: 10.1111/cts.12408. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center